HighMark Wealth Management LLC

SEC CIK: 0001802451
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by HighMark Wealth Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of RARE by HighMark Wealth Management LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−209−100.0%	Sold out	Holders
Q3 2021	209	$19.0K	<0.1%	+113+117.7%	Added	Holders
Q2 2021	96	$9.00K	<0.1%	+13+15.7%	Added	Holders
Q1 2021	83	$9.00K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.